Last reviewed · How we verify

NCT05269927

A Multi-domain Approach for the Characterization and Early Diagnosis of Neurodevelopmental Disorders

Completed NA Last updated 8 March 2022
What this trial tests

NA trial testing EEG in Neurodevelopmental Disorders in 300 participants. Completed in 31 May 2021.

Timeline
1 March 2016
Primary endpoint
31 May 2021
31 May 2021

Quick facts

Lead sponsorIRCCS Eugenio Medea
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment300
Start date1 March 2016
Primary completion31 May 2021
Estimated completion31 May 2021
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

IRCCS Eugenio Medea — full company profile →

Who can join

Adults 5 Months to 7 Months, any sex, with Neurodevelopmental Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Diagnosis and characterization of neurodevelopmental disorders are considered challenging processes because of their complexity, multi-factoriality and heterogeneity. The present project will consider two of the most common neurodevelopmental disorders (i.e. autism spectrum disorders (ASD) and language disorders (LD)), with the aim to overcome these difficulties, by: a) deeply investigating their neuronal correlates; b) identifying multi-domain biomarkers (electrophysiological, genetic, environmental and clinical); c) developing a machine learning algorithm for early diagnosis. To achieve the above mentioned aims a multi-domain dataset will be used, comprising data collected from typically developing infants, infants at high risk for ASD and infants at high risk for LD. The data that will be used have been already collected within other trials performed at the Scientific Institute E. Medea.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of EEG

Trials testing the same drug.

Other recruiting trials for Neurodevelopmental Disorders

Currently open trials in the same condition.

Other IRCCS Eugenio Medea trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05269927.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing